Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP156087.RAezrirUil7ETiHvL4tgUsrMlpdPcguXcIpweAKVBcHXM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP156087.RAezrirUil7ETiHvL4tgUsrMlpdPcguXcIpweAKVBcHXM130_assertion type Assertion NP156087.RAezrirUil7ETiHvL4tgUsrMlpdPcguXcIpweAKVBcHXM130_head.
- NP156087.RAezrirUil7ETiHvL4tgUsrMlpdPcguXcIpweAKVBcHXM130_assertion description "[The role of KRAS mutations in predicting the efficacy of cetuximab-plus-irinotecan therapy in irinotecan-refractory Korean metastatic colorectal cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP156087.RAezrirUil7ETiHvL4tgUsrMlpdPcguXcIpweAKVBcHXM130_provenance.
- NP156087.RAezrirUil7ETiHvL4tgUsrMlpdPcguXcIpweAKVBcHXM130_assertion evidence source_evidence_literature NP156087.RAezrirUil7ETiHvL4tgUsrMlpdPcguXcIpweAKVBcHXM130_provenance.
- NP156087.RAezrirUil7ETiHvL4tgUsrMlpdPcguXcIpweAKVBcHXM130_assertion SIO_000772 19738388 NP156087.RAezrirUil7ETiHvL4tgUsrMlpdPcguXcIpweAKVBcHXM130_provenance.
- NP156087.RAezrirUil7ETiHvL4tgUsrMlpdPcguXcIpweAKVBcHXM130_assertion wasDerivedFrom gad-20150221 NP156087.RAezrirUil7ETiHvL4tgUsrMlpdPcguXcIpweAKVBcHXM130_provenance.
- NP156087.RAezrirUil7ETiHvL4tgUsrMlpdPcguXcIpweAKVBcHXM130_assertion wasGeneratedBy ECO_0000203 NP156087.RAezrirUil7ETiHvL4tgUsrMlpdPcguXcIpweAKVBcHXM130_provenance.